Search

Author/Creator Wislez, M

1. 1142PDEfficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort. (23rd October 2018)

Authors:
Domblides, C; Monnet, I; Mazieres, J; Barlesi, F; Gounant, V; Baldacci, S; Mennecier, B; Toffart, A C; Audigier Valette, C; Doucet, L; Giroux-Leprieur, E; Guisier, F; Molinier, O; Perol, M; Pichon, E; Robinet, G; Templement Grangerat, D; Ruppert, A-M; Wislez, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. (4th October 2019)

Authors:
Moro-Sibilot, D; Cozic, N; Pérol, M; Mazières, J; Otto, J; Souquet, P J; Bahleda, R; Wislez, M; Zalcman, G; Guibert, S D; Barlési, F; Mennecier, B; Monnet, I; Sabatier, R; Bota, S; Dubos, C; Verriele, V; Haddad, V; Ferretti, G; Cortot, A
Journal:
Annals of oncology
Issue:
Volume 30:Number 12(2019)
Page Start:
1985
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗